RAMM Pharma Corp. (CSE:RAMM)
Canada · Delayed Price · Currency is CAD 0.0100
+0.0050 (100.00%)
Oct 29, 2026, 4:48 PM EDT
RAMM Pharma Revenue
RAMM Pharma had revenue of 260.01K CAD in the quarter ending July 31, 2026, a decrease of -70.56%. This brings the company's total for the last twelve months to 1.27M, down -66.40% year-over-year. In the fiscal year ending October 31, 2025, RAMM Pharma had annual revenue of 3.36M, down -22.60%. That makes RAMM Pharma the 43,756th largest company in the world by revenue and 914th in Canada.
Revenue (ttm)
1.27M
Revenue Growth
-66.40%
P/S Ratio
0.94
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.19M
Revenue by Geography
- Uruguay 2.22M 66.0%
- Poland 1.14M 34.0%
Fiscal year ended Oct 31, 2025 See the full RAMM Pharma breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 3.36M | -981.34K | -22.60% |
| Oct 31, 2024 | 4.34M | -723.29K | -14.28% |
| Oct 31, 2023 | 5.07M | 1.17M | 29.96% |
| Oct 31, 2022 | 3.90M | -218.63K | -5.31% |
| Oct 31, 2021 | 4.12M | -1.33M | -24.40% |
| Oct 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Vibe Growth | 26.34M |
| Adastra Holdings | 16.86M |
| Vencanna Ventures | 2.56M |
| Aequus Pharmaceuticals | 918.47K |
| Ovation Science | 57.34K |
| Genix Pharmaceuticals | 68.00 |
| Captor Capital | -5.05M |